1 Department of Chemistry, The University of Kansas-Lawrence, Lawrence, Kansas 66045.
2 Departments of Chemistry, Molecular Biosciences and Pharmaceutical Chemistry, The University of Kansas-Lawrence, Lawrence, Kansas 66047.
3 Lawrence, Kansas 66047.
4 Department of Pharmacy, Uppsala University, Uppsala SE-751 23, Sweden.
5 School of Pharmacy, The University of Kansas-Lawrence, Lawrence, Kansas 66047.
6 Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven 3000, Belgium.
7 Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
8 Drug Disposition, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285. Electronic address: raubtj@lilly.com.
9 Department of Pharmaceutical Chemistry, The University of Kansas-Lawrence, Lawrence, Kansas 66047.
10 Department of Biopharmaceutics and Drug Metabolism Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
11 Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.
12 Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.